ASCO 2021: Updated results of MONALEESA-3 show sustained overall survival benefits with ribociclib in advanced breast cancer June 15, 2021
ASCO 2021: HER2CLIMB update shows benefits of adding tucatinib to trastuzumab & capecitabine are maintained in metastatic breast cancer June 4, 2021